Praxis Precision Medicines (PRAX) Stock Insights

PRAX price $285.48 +17.89 +6.69%

Ticker
PRAX
Price
$285.48
Change
+17.89 +6.69%
Market cap ?
$7.97B
P/E ?
-20.65
Forward P/E ?
53.24
Dividend yield ?
0.00%
Beta ?
2.81
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
65
Value
48
Quality
48
Growth
100

Stocklytics score rationale: value 48, quality 48, growth 100.

Financials

20182019202020212022202320242025
00000244700085530000

Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity. The company's primary investigational compounds currently undergoing evaluation include: PRAX-114, an extrasynaptic-preferring positive allosteric modulator of the GABAA receptor, which…

Fair value

PRAX fair value $113.09. Price $285.48. Price is 152% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 2.81M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 27.92M. Net debt -357.22M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare PRAX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-3.54—130.77K
2026-08-06-2.87-3.67—1.25M
2026-05-07-3.20-3.58—100.00K
2026-02-19-3.50-3.13—66.67K
2025-11-05-3.36-3.45—256.09K
2025-08-04-3.31-3.40—59.44K
2025-05-02-3.29-3.20—198.80K
2025-02-28-2.94-2.767.46M297.88K
2024-11-06-2.75-2.01302.00K365.00K
2024-08-13-1.74-2.38357.00K830.00K
2024-05-13-2.84-2.01431.00K1.62M
2024-03-05-2.97-3.15515.00K50.00K
2023-11-07-2.70-5.25468.00K—
2023-08-09-7.35-9.90781.00K—
2023-05-11-10.64-11.24683.00K—
2023-02-07-13.04-10.94——
2022-11-09-14.39-13.79——
2022-08-08-19.79-19.49——
2022-05-09-22.64-19.34——
2022-02-28-19.49-16.19——
2021-11-03-14.99-13.94——
2021-08-16-13.19-10.19——
2021-05-11-10.64-11.09——
2021-03-17-13.04-5.70——
2020-11-23-12.10-0.73——
2020-10-16-105.64———
2020-03-31-76.69———
2019-12-31-68.71———
2019-09-30-101.99———
2019-06-30-100.35———
2019-03-31-100.35———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-08Souza MarcioSell20.52K——
2026-07-08Souza MarcioSell2.60K——
2026-06-24DeSimone JillBuy3.03K$147.30446.91K
2026-06-24DeSimone JillSell10$301.443.01K
2026-06-24DeSimone JillSell120$303.1336.38K
2026-06-24DeSimone JillSell320$305.3197.70K
2026-06-24DeSimone JillSell683$306.77209.52K
2026-06-24DeSimone JillSell1.24K$308.24382.22K
2026-06-24DeSimone JillBuy8.57K$44.25379.05K
2026-06-24DeSimone JillSell999$309.38309.07K
2026-06-24DeSimone JillSell1.75K$310.89544.06K
2026-06-24DeSimone JillSell2.85K$311.91890.20K
2026-06-24DeSimone JillSell1.00K$312.83314.08K
2026-06-24DeSimone JillSell504$313.66158.09K
2026-06-24DeSimone JillSell1.28K$314.90402.76K
2026-06-24DeSimone JillSell837$315.70264.25K
2026-06-24DeSimone JillSell8.57K$44.25379.05K
2026-06-24DeSimone JillSell3.03K$147.30446.91K
2026-06-10Arbuckle Stuart ABuy1.37K——
2026-06-10Arbuckle Stuart ABuy648$240.66155.95K
2026-06-10Chodakewitz JeffreyBuy1.37K——
2026-06-10Chodakewitz JeffreyBuy648$240.66155.95K
2026-06-10YOUNG WILLIAM DBuy1.37K——
2026-06-10YOUNG WILLIAM DBuy648$240.66155.95K
2026-06-10DeSimone JillBuy1.37K——
2026-06-10DeSimone JillBuy648$240.66155.95K
2026-06-10Cudkowicz Merit EsterBuy1.37K——
2026-06-10Cudkowicz Merit EsterBuy648$240.66155.95K
2026-06-10MITCHELL DEAN JBuy1.37K——
2026-06-10MITCHELL DEAN JBuy648$240.66155.95K
2026-06-10KINDLER JEFFREY BBuy1.37K——
2026-06-10KINDLER JEFFREY BBuy648$240.66155.95K
2026-06-10Norden GregoryBuy1.37K——
2026-06-10Norden GregoryBuy648$240.66155.95K
2026-05-14Mastrocola LaurenBuy127$167.9421.33K
2026-05-14Nemiroff AlexBuy78$167.9413.10K
2026-05-14Kelly Timothy EdwinBuy121$167.9420.32K
2026-05-14Sniecinski MeganBuy89$167.9414.95K
2026-05-14Souza MarcioBuy126$167.9421.16K
2026-02-06Arbuckle Stuart ABuy478——
2026-02-06Arbuckle Stuart ABuy688——
2026-02-06Arbuckle Stuart ABuy224$319.5771.58K
2026-02-06KINDLER JEFFREY BBuy478——
2026-02-06KINDLER JEFFREY BBuy688——
2026-02-06KINDLER JEFFREY BBuy224$319.5771.58K
2026-01-12Mastrocola LaurenSell344$275.7494.85K
2026-01-12Sniecinski MeganSell885$275.74244.03K
2026-01-12Nemiroff AlexSell768$275.74211.77K
2026-01-12Kelly Timothy EdwinSell943$275.74260.02K
2026-01-10Mastrocola LaurenSell367$288.45105.86K
2026-01-10Sniecinski MeganSell1.09K$288.45313.55K
2026-01-10Nemiroff AlexSell917$288.45264.51K
2026-01-10Kelly Timothy EdwinSell1.33K$288.45385.08K
2026-01-10Souza MarcioSell4.25K$288.451.23M
2026-01-08Mastrocola LaurenBuy3.75K——
2026-01-08Mastrocola LaurenBuy7.50K$294.382.21M
2026-01-08Sniecinski MeganBuy9.62K——
2026-01-08Sniecinski MeganBuy7.70K$294.382.27M
2026-01-08Nemiroff AlexBuy6.88K——
2026-01-08Nemiroff AlexBuy5.50K$294.381.62M
2026-01-08Kelly Timothy EdwinBuy8.80K——
2026-01-08Kelly Timothy EdwinBuy7.04K$294.382.07M
2026-01-08Souza MarcioBuy27.64K——
2026-01-08Souza MarcioBuy22.11K$294.386.51M
2026-01-08Arbuckle Stuart AOther0——
2026-01-08KINDLER JEFFREY BOther0——
2026-01-07Mastrocola LaurenSell35$292.6310.24K
2026-01-07Nemiroff AlexSell89$292.6326.04K
2026-01-07Kelly Timothy EdwinSell139$292.6340.68K
2026-01-07Souza MarcioSell405$292.63118.52K
2026-01-01Sniecinski MeganOther0——
2026-01-01Sniecinski MeganOther30.00K$43.371.30M
2026-01-01Sniecinski MeganOther821$31.8026.11K
2026-01-01Sniecinski MeganOther10.00K$44.40443.96K
2026-01-01Sniecinski MeganOther36.40K$56.942.07M
2026-01-01Sniecinski MeganOther22.50K$63.151.42M
2026-01-01Sniecinski MeganOther12.00K$257.253.09M
2025-12-30Souza MarcioSell400——
2025-11-20Nemiroff AlexBuy9.10K$56.94518.15K
2025-11-20Nemiroff AlexSell1.71K$190.86327.14K
2025-11-20Nemiroff AlexBuy5.65K$44.40250.95K
2025-11-20Nemiroff AlexBuy2.43K$44.40108.07K
2025-11-20Nemiroff AlexSell13.34K$192.532.57M
2025-11-20Nemiroff AlexSell977$193.23188.79K
2025-11-20Nemiroff AlexBuy6.23K$133.65832.64K
2025-11-20Nemiroff AlexBuy1.71K$83.85143.72K
2025-11-20Nemiroff AlexSell9.10K$194.301.77M
2025-11-20Nemiroff AlexSell9.10K$56.94518.15K
2025-11-20Nemiroff AlexSell5.65K$44.40250.95K
2025-11-20Nemiroff AlexSell2.43K$44.40108.07K
2025-11-20Nemiroff AlexSell6.23K$133.65832.64K
2025-11-20Nemiroff AlexSell1.71K$83.85143.72K
2025-11-20Mastrocola LaurenBuy5.25K$56.94298.94K
2025-11-20Mastrocola LaurenBuy2.35K$44.40104.38K
2025-11-20Mastrocola LaurenBuy207$44.409.19K
2025-11-20Mastrocola LaurenBuy2.68K$43.37116.23K
2025-11-20Mastrocola LaurenBuy1.56K$133.65208.09K
2025-11-20Mastrocola LaurenSell11.46K$191.962.20M
2025-11-20Mastrocola LaurenBuy508$83.8542.60K
2025-11-20Mastrocola LaurenBuy1.05K$49.5051.83K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 330, holders +19 vs prior quarter. Ownership 116.55%.

HolderSharesChangeChange %Value
JUPITER TOPCO LLC3.42M3.42MNew1.15B
FMR LLC2.32M155.96K+7.22%775.68M
BLACKROCK, INC.2.29M-32.34K-1.39%767.53M
PERCEPTIVE ADVISORS LLC2.04M00.00%681.63M
BAKER BROS. ADVISORS LP1.75M00.00%586.95M
ORBIS ALLAN GRAY LTD1.53M-942.69K-38.13%512.16M
VANGUARD PORTFOLIO MANAGEMENT LLC1.34M578.44K+76.44%447.01M
VANGUARD CAPITAL MANAGEMENT LLC1.24M13.36K+1.09%413.57M
STATE STREET CORP1.03M142.21K+16.08%343.66M
ADAGE CAPITAL PARTNERS GP, L.L.C.1.02M199.74K+24.49%339.97M
DEERFIELD MANAGEMENT COMPANY, L.P.963.35K00.00%322.52M
DRIEHAUS CAPITAL MANAGEMENT LLC959.05K9.82K+1.03%321.08M
PRICE T ROWE ASSOCIATES INC /MD/943.00K312.15K+49.48%315.71M
MORGAN STANLEY854.11K20.62K+2.47%285.95M
GEODE CAPITAL MANAGEMENT, LLC748.04K97.14K+14.92%250.48M
CORMORANT ASSET MANAGEMENT, LP640.00K-245.50K-27.72%214.27M
GOLDMAN SACHS GROUP INC548.83K-161.90K-22.78%183.74M
BANK OF AMERICA CORP /DE/546.93K12.33K+2.31%183.11M
INVESCO LTD.537.55K476.15K+775.53%179.97M
HOOD RIVER CAPITAL MANAGEMENT LLC425.17K66.55K+18.56%142.34M
NORGES BANK346.97K346.97KNew116.16M
FRANKLIN TEMPLETON INC327.12K51.00K+18.47%109.52M
PICTET ASSET MANAGEMENT HOLDING SA291.69K5.04K+1.76%98.04M
POLAR CAPITAL HOLDINGS PLC279.13K279.13KNew93.45M
VIVO CAPITAL, LLC271.12K-67.78K-20.00%90.77M

Insights

Revenue by product
PeriodValue
FY2022License: 98500000.0
FY2023License: 2400000.0
FY2024License: 8600000.0, Upfront Payment: 2600000.0

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Praxis Precision Medicines (PRAX) Stock Insights

PRAX$285.48+17.89 +6.69%

$7.97B

Market Cap

-20.65

P/E

53.24

Forward P/E

65

Score

Price History